Pyelonephritis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Pyelonephritis}} | {{Pyelonephritis}} | ||
==Overview== | |||
According to an estimate the mean cost of diagnosing and managing a patient with [[urinary tract infection]] including pyelonephritis is more than 229 pounds per year. [[Hyaluronan]] therapy given long term cuts down the cost of multiple pretreatments as it prevents recurrence of a [[Urinary tract infection]].<ref name="pmid23921624">{{cite journal| author=Riedl C, Engelhardt P, Schwarz B| title=Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines. | journal=Clin Drug Investig | year= 2013 | volume= 33 | issue= 10 | pages= 737-42 | pmid=23921624 | doi=10.1007/s40261-013-0119-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23921624 }} </ref><ref name="pmid23475540">{{cite journal| author=Ciani O, Grassi D, Tarricone R| title=An economic perspective on urinary tract infection: the "costs of resignation". | journal=Clin Drug Investig | year= 2013 | volume= 33 | issue= 4 | pages= 255-61 | pmid=23475540 | doi=10.1007/s40261-013-0069-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23475540 }} </ref> | |||
==Cost-effective therapies== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 21:57, 27 January 2017
|
Pyelonephritis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pyelonephritis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Pyelonephritis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Pyelonephritis cost-effectiveness of therapy |
Overview
According to an estimate the mean cost of diagnosing and managing a patient with urinary tract infection including pyelonephritis is more than 229 pounds per year. Hyaluronan therapy given long term cuts down the cost of multiple pretreatments as it prevents recurrence of a Urinary tract infection.[1][2]
Cost-effective therapies
References
- ↑ Riedl C, Engelhardt P, Schwarz B (2013). "Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines". Clin Drug Investig. 33 (10): 737–42. doi:10.1007/s40261-013-0119-4. PMID 23921624.
- ↑ Ciani O, Grassi D, Tarricone R (2013). "An economic perspective on urinary tract infection: the "costs of resignation"". Clin Drug Investig. 33 (4): 255–61. doi:10.1007/s40261-013-0069-x. PMID 23475540.